Cantor Fitzgerald resumed coverage on Longboard Pharmaceuticals with a new price target

10/24/23 6:13:42 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $LBPH alert in real time by email

Cantor Fitzgerald resumed coverage of Longboard Pharmaceuticals with a rating of Overweight and set a new price target of $35.00 from $16.00 previously

Get the next $LBPH alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LBPH

Date	Price Target	Rating	Analyst
9/10/2024	$60.00	Buy	Truist
7/1/2024	$60.00 → $90.00	Overweight	Cantor Fitzgerald
5/1/2024	$36.00	Outperform	Robert W. Baird
2/16/2024	$40.00	Buy	Citigroup
10/24/2023	$16.00 → $35.00	Overweight	Cantor Fitzgerald
4/27/2023	$13.00	Buy	B. Riley Securities
2/14/2022	$14.00	Outperform	Wedbush

More analyst ratings

Cantor Fitzgerald resumed coverage on Longboard Pharmaceuticals with a new price target

Chat with this insight

Recent Analyst Ratings for $LBPH

Recent Analyst Ratings for
$LBPH